Inventor profile of:

Sung Soo JUN

City:

Gyeonggi-do

Country:

South Korea

Published Applications:

19

Last publication date:

2018-09-13

Top Assignees for applications by Sung Soo JUN

The entities that hold a legal rights for patent applications filed by inventor JUN Sung Soo:

Recent patent applications by JUN Sung Soo

Sung Soo JUN from Gyeonggi-do, KR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-09-13
US20180256520A1
Human necessities

Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient

#2 | 2016-11-03
US20160317478A1
Human necessities

Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient

#3 | 2015-12-31
US20150376123A1
Chemistry; metallurgy

Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient

#4 | 2013-09-12
US20130237472A1
Chemistry; metallurgy

Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same

#5 | 2013-04-04
US20130084329A1
Human necessities

COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASES

#6 | 2013-03-21
US20130071471A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING ATOPIC DERMATITIS

#7 | 2012-12-06
US20120309799A1
Human necessities

Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient

#8 | 2012-11-08
US20120283299A1
Human necessities

Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient

#9 | 2012-01-19
US20120015032A1
Human necessities

COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME

#10 | 2012-01-12
US20120010287A1
Human necessities

N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same

#11 | 2011-09-29
US20110237587A1
Chemistry; metallurgy

1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same

#12 | 2011-06-09
US20110135714A1
Human necessities

COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES

#13 | 2011-05-26
US20110123612A1
Human necessities

PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKER

#14 | 2010-09-30
US20100249241A1
Chemistry; metallurgy

N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same

#15 | 2010-06-10
US20100143470A1
Human necessities

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING THIAZIDES AND ANGIOTENSIN-II-RECEPTOR BLOCKERS

#16 | 2010-04-08
US20100087544A1
Human necessities

N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same

#17 | 2009-05-28
US20090137523A1
Human necessities

Compositions for External Application, Containing Adenosyl Cobalamin for Improvement of Skin Diseases

#18 | 2008-10-02
US20080241240A1
Human necessities

COMBINED PHARMACEUTICAL FORMULATION WITH CONTROLLED-RELEASE COMPRISING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AND HMG-COA REDUCTASE INHIBITORS

#19 | 2008-02-28
US20080050432A1
Human necessities

Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors

InventorID:

152097 ⎘